Adhera Therapeutics, Inc. Quarterly Debt-to-equity in % from Q1 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Adhera Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2023.
  • Adhera Therapeutics, Inc. Debt-to-equity for the quarter ending September 30, 2023 was -100 %, a 1.39% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 -100 +1.41 +1.39% Sep 30, 2023
Q2 2023 -101 +1.07 +1.05% Jun 30, 2023
Q1 2023 -102 -0.99 -0.98% Mar 31, 2023
Q4 2022 -102 -1.15 -1.14% Dec 31, 2022
Q3 2022 -102 -1.39 -1.39% Sep 30, 2022
Q2 2022 -102 -1.43 -1.43% Jun 30, 2022
Q1 2022 -101 -0.22 -0.22% Mar 31, 2022
Q4 2021 -101 +0.53 +0.53% Dec 31, 2021
Q3 2021 -100 +1.59 +1.56% Sep 30, 2021
Q2 2021 -100 +12.3 +10.9% Jun 30, 2021
Q1 2021 -100 +25.3 +20.1% Mar 31, 2021
Q4 2020 -101 +59.8 +37.2% Dec 31, 2020
Q3 2020 -102 +332 +76.5% Sep 30, 2020
Q2 2020 -112 Jun 30, 2020
Q1 2020 -126 Mar 31, 2020
Q4 2019 -161 Dec 31, 2019
Q3 2019 -434 Sep 30, 2019
Q4 2016 281 +753 Dec 31, 2016
Q3 2016 429 +1.1K Sep 30, 2016
Q2 2016 909 +1.25K Jun 30, 2016
Q1 2016 -1.85K -1.5K -431% Mar 31, 2016
Q4 2015 -472 -146 -44.7% Dec 31, 2015
Q3 2015 -670 -422 -170% Sep 30, 2015
Q2 2015 -340 -71.6 -26.7% Jun 30, 2015
Q1 2015 -349 -105 -42.9% Mar 31, 2015
Q4 2014 -326 -86.9 -36.4% Dec 31, 2014
Q3 2014 -248 +0.16 +0.07% Sep 30, 2014
Q2 2014 -268 +10.1 +3.62% Jun 30, 2014
Q1 2014 -244 +87.7 +26.4% Mar 31, 2014
Q4 2013 -239 +137 +36.4% Dec 31, 2013
Q3 2013 -248 +394 +61.4% Sep 30, 2013
Q2 2013 -278 -745 -160% Jun 30, 2013
Q1 2013 -332 -518 -278% Mar 31, 2013
Q4 2012 -376 Dec 31, 2012
Q3 2012 -642 Sep 30, 2012
Q2 2012 466 Jun 30, 2012
Q1 2012 186 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.